Tag: University-of-Pennsylvania

2 articles

Research

Penn's AI app lets epilepsy patients chat with their brain monitors

A University of Pennsylvania app let 13 epilepsy patients in hospital text questions to the system reading their brain activity and mark its seizure alarms as right or wrong, in a study published in Nature Medicine on 13 October 2026. In a simulation run afterwards, retraining on those answers cut false alarms by 80 per cent. Penn holds a provisional patent, has named no commercial partner, and is preparing a Parkinson's study.

Oct 16

Market Moves

Nia Therapeutics gets FDA Breakthrough Designation for a preclinical TBI memory implant

Nia Therapeutics, an Allston Massachusetts company co-founded in 2018 by University of Pennsylvania memory neuroscientist Michael Kahana and cognitive neuromodulation researcher Daniel Rizzuto, received FDA Breakthrough Device Designation on 13 March 2026 for its Smart Neurostimulation System (SNS), indicated for episodic memory loss in adults with prior moderate-to-severe traumatic brain injury. The SNS is a 60-channel wireless closed-loop cortical implant whose platform hardware was validated in a sheep study published in Brain Stimulation in December 2025. It is preclinical: no human implant yet, IDE application planned for 2026.

Jul 5